MEDIPOST Co., Ltd. engages in the cord blood bank business in South Korea and internationally. The company operates through three divisions: Cord Blood Bank, Stem Cell Therapy, and Health Functional Food. It operates cord blood bank under the CELLTREE name. The company also offers CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthritis. In addition, it is developing stem cell products, such as PNEUMOSTEM for the preventative treatment of bronchopulmonary dysplasia. Further, the company develops SMUP-IA-01 to treat osteoarthritis; and SMUP-IV-01 for the treatment of diabetic nephropathy. Additionally, it offers nutritional and dietary supplements under the MOVITA brand name; and CDMO services. The company was founded in 2000 and is headquartered in Seongnam-si, South Korea.
Metrics to compare | 078160 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship078160PeersSector | |
---|---|---|---|---|
P/E Ratio | −5.1x | 9.9x | −0.6x | |
PEG Ratio | 0.00 | 0.01 | 0.00 | |
Price/Book | 1.5x | 1.4x | 2.6x | |
Price / LTM Sales | 5.1x | 1.9x | 3.3x | |
Upside (Analyst Target) | - | 49.2% | 39.1% | |
Fair Value Upside | Unlock | 2.0% | 5.4% | Unlock |